HomeLPTX • NASDAQ
add
Leap Therapeutics Inc
Previous close
$3.39
Day range
$3.01 - $3.34
Year range
$1.68 - $4.79
Market cap
117.08M USD
Avg Volume
369.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.35M | 28.54% |
Net income | -18.18M | -32.71% |
Net profit margin | — | — |
Earnings per share | -0.44 | 13.73% |
EBITDA | -18.35M | -28.57% |
Effective tax rate | -4.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.82M | -22.19% |
Total assets | 65.05M | -21.67% |
Total liabilities | 16.09M | 45.80% |
Total equity | 48.95M | — |
Shares outstanding | 38.32M | — |
Price to book | 2.64 | — |
Return on assets | -62.65% | — |
Return on capital | -79.39% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -18.18M | -32.71% |
Cash from operations | -15.60M | -48.74% |
Cash from investing | — | — |
Cash from financing | -66.00K | -6,500.00% |
Net change in cash | -15.66M | -46.70% |
Free cash flow | -9.45M | -38.37% |
About
Founded
2011
Website
Employees
54
